Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Tisotumab Vedotin, Datopotamab Deruxtecan Among Products Awaiting EMA Verdict
Jan 27 2025
•
By
Vibha Sharma
Several sponsors are due to learn if their products will get a thumbs up from the EMA • Source: Shutterstock
More from EU CHMP
More from Pink Sheet